Oliver Jan Jüngst (left) and Daniela Kinkeldey of Bird & Bird
Oliver Jan Jüngst and Daniela Kinkeldey of Bird & Bird explain how they secured victory for client NanoString in the first major ruling by the UPC’s Court of Appeal
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents